United States News Todas as matérias

Kandi Technologies (NASDAQ:KNDI) has agreed to acquire a 51% controlling stake in Hangzhou Xinchu New Energy for RMB20 million, approximately US$2.9 million, in cash.

Daiichi Sankyo and AstraZeneca (NASDAQ:AZN) announced that Enhertu (trastuzumab deruxtecan) has been approved in the European Union as monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (IHC 3+) solid tumors who have received prior treatment and who have no satisfactory alternative treatment options.

AbbVie (NYSE:ABBV) said the CHMP has issued a positive opinion recommending approval of upadacitinib (RINVOQ) 15 mg and 30 mg once daily for adults and adolescents with severe alopecia areata in the EU.

Waymo, owned by Alphabet (NASDAQ:GOOGL), has ended its Phoenix robotaxi availability on Uber Technologies (NYSE:UBER), closing a pilot that delivered hundreds of thousands of autonomous trips.

BCAL Diagnostics (ASX:BDX), an Australian healthcare company focused on early cancer detection, has secured firm commitments for a further A$4.9 million under its existing A$10 million convertible note facility, with the additional funds to be drawn down as required.

CMB.TECH (NYSE:CMBT) announced the sale of two 2023-built Suezmax tankers, Brest and Brugge, each with a deadweight tonnage of 156,851.

NeuroSense Therapeutics (NASDAQ:NRSN) reported that its Phase 2b PARADIGM study of PrimeC in amyotrophic lateral sclerosis met its primary endpoint, showing a statistically significant reduction in neuron-derived TDP-43 compared with placebo at Day 180.

Replimune (NASDAQ:REPL) reported fiscal 2026 results with a net loss of $313.9 million, research and development expenses of $221.2 million, and selling, general and administrative expenses of $98.7 million.

The Albanese Government plans to strengthen Australia’s social media minimum age law by giving the eSafety Commissioner broader information‑gathering powers and doubling the maximum penalty for systematic breaches from $49.5 million to $99 million.

Hawk Resources (ASX:HWK) has reported new lab assays from hole DD26CT004 at its Cactus copper‑gold project in Utah, intersecting 72.9m at 0.36% copper and 2.0ppm silver from 18m below surface and confirming more near surface copper, silver and molybdenum in the Cactus Corridor.

• BlackBerry reported Q1 FY2027 revenue of $152.9 million, up 26% year over year, with adjusted EBITDA of $36.3 million and GAAP operating income of $15.3 million.
• The comparison group shows a wide revenue gap, from Cerence’s $64.2 million quarterly revenue to Palo Alto Networks’ $3 billion quarterly revenue.
• The main sector test is whether AI security, connected-vehicle software, and government communications can keep growing while margins stay under control.

• Micron Technology reported $41.46 billion in quarterly revenue as the firm capitalized on surging data center component demand.
• The semiconductor manufacturer recorded a GAAP net income of $28.24 billion and declared a quarterly dividend of $0.15 per share.
• Global hardware manufacturers must carefully secure raw materials to execute aggressive revenue projections amid volatile enterprise capital expenditures.

• FedEx reported $25 billion in fourth-quarter fiscal 2026 revenue while executing a spin-off of its freight division to consolidate core operations.
• The logistics provider exceeded cost-cutting targets by securing over $1 billion in structural savings and achieving an adjusted earnings per share of $6.60.
• Global transportation firms face mounting pressure to offset mixed profitability trends by heavily reducing capital spending and divesting secondary business units.

• AbbVie agreed to acquire Apogee Therapeutics in a $10.9 billion all-cash transaction, paying a 60% premium to secure a late-stage immunology pipeline.
• The company will pay $135.11 per share, with executives projecting the deal will not become accretive to adjusted earnings until 2032.
• Large pharmaceutical manufacturers face intense capital pressure to acquire unproven, long-acting biologics to offset impending revenue losses from patent expirations.

• Federal authorities are investigating WiseTech Global (ASX:WTC) executive chairman Richard White over visa fraud and human trafficking allegations.
• The ongoing controversy triggered a sharp market sell-off, pulling the WiseTech share price down to $36.88.
• Institutional investors are reassessing sector governance and operational risk amid wider software industry headwinds.

Vox Royalty (NASDAQ:VOXR) agreed to sell its capped gold offtake stream tied to i-80 Gold assets for $4.8 million, with consideration payable entirely in freely tradeable i-80 Gold common shares.

Modular Medical (NASDAQ:MODD) said it has begun shipping Pivot tubeless insulin patch pump starter kits to endocrinology practices to support physician training before wider patient access.

Aethlon Medical (NASDAQ:AEMD) announced peer-reviewed Long COVID research showing roughly two-fold higher mannose-positive extracellular vesicles in patient samples.

Ensysce Biosciences (NASDAQ:ENSC) announced that the first patient has been enrolled in the final stage of the PF614-MPAR-102 clinical study.

Locafy (NASDAQ:LCFY) reported total operating revenue of AUD 3.1 million for the nine months ended March 31, 2026, representing 31% growth year over year.

Replimune (NASDAQ:REPL) announced that the U.S. Food and Drug Administration has accepted for review the company’s resubmitted Biologics License Application for RP1 (vusolimogene oderparepvec) in combination with nivolumab for the treatment of advanced melanoma.

Quantum Cyber (NASDAQ:QUCY) announced that its Board of Directors has approved engaging investment banks to pursue the acquisition of an equity stake in SpaceX (NASDAQ:SPCX).

RTX (NYSE:RTX) announced that its Raytheon business has been awarded a $1.1 billion contract by the U.S. Navy to produce AIM-9X Block II missiles, along with related hardware and software.

Cineverse (NASDAQ:CNVS) reported fourth quarter fiscal 2026 revenue of $26 million, an increase of 67% from the prior-year period.